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Abstract. Leptospirosis is an important zoonosis worldwide, with infections occurring after exposure to contaminated
water. Despite being a global problem, laboratory diagnosis remains difficult with culture results taking up to 3 months,
serology being retrospective by nature, and polymerase chain reaction showing limited sensitivity. Leptospira have been
shown to survive and multiply in blood culture media, and we hypothesized that extracting DNA from incubated blood
culture fluid (BCF), followed by quantitative real-time polymerase chain reaction (qPCR) could improve the accuracy
and speed of leptospira diagnosis. We assessed this retrospectively, using preincubated BCF of Leptospira spp. positive
(N = 109) and negative (N = 63) febrile patients in Vientiane, Lao PDR. The final method showed promising sensitivities
of 66% (95% confidence interval [CI]: 55–76) and 59% (95% CI: 49–68) compared with direct or direct and indirect test-
ing combined, as the respective reference standards (specificities > 95%). Despite these promising diagnostic parameters,
a subsequent prospective evaluation in a Lao hospital population (N = 352) showed that the sensitivity was very low
(∼30%) compared with qPCR on venous blood samples. The disappointingly low sensitivity does suggest that venous
blood samples are preferable for the clinical microbiology laboratory, although BCF might be an alternative if leptospirosis
is only suspected postadmission after antibiotics have been used.
INTRODUCTION
Leptospirosis is a worldwide zoonotic disease, particularly
common in rural tropical regions associated with contaminated
water and soil exposure during heavy rainfall and occupational
risks.1 Poor living conditions in urban slums also contribute to
an apparently increasing numbers of cases.2 Leptospiral infec-
tions are difficult to differentiate clinically from many other
important causes of fever in the tropics, for example, rickettsial
infections, typhoid, dengue, and malaria. In the United Kingdom
and other temperate zones, cases may be indigenously associ-
ated with occupational or recreational risk factors or acquired
overseas, predominantly in Southeast Asia or Central America.3
Leptospirosis usually presents as a nonspecific febrile illness,
but may progress to serious renal, pulmonary, and central ner-
vous system complications, with a case fatality rate of up to
40%.4,5 A lack of accurate diagnostic tools makes individual
patient diagnosis to guide treatment very difficult.6–9 Serologi-
cal methods are of limited use at admission, particularly in
populations with regular exposure to the pathogen in whom
only a 4-fold rise between admission and convalescent samples
indicates recent infection. The organism is slow-growing and
fastidious, requiring specialized prolonged culture methods
and media10; hence for timely diagnosis, molecular tools have
emerged as the methodologies of choice.11 Several molecular
methods have been developed mostly using venous (ethylene-
diaminetetraacetic acid [EDTA]) blood.9,11,12 We recently
demonstrated the utility of molecular diagnosis of Orientia
tsutsugamushi, the agent of scrub typhus, from blood culture
fluid (BCF) after 24-hour incubation (S. Dittrich, submitted).
It has also been shown that Leptospira spp. survive in conven-
tional blood culture media for up to 14 days but were not
detected by conventional alert systems.13,14 Villumsen and
others14 explored the use of BCF in place of venous blood as a
sample for early leptospira diagnosis even days after antibiotic
therapy initiation. Such techniques, especially if there was
bacterial multiplication in blood cultures before quantitative
real-time polymerase chain reaction (qPCR), could increase
the sensitivity of assays and give additional sample matrices
to work with. We, therefore, performed an initial pilot
proof-of-principle and then a prospective study to determine
whether blood culture bottles incubated for 24 hours in the
Microbiology Laboratory of Mahosot Hospital (Vientiane,
Lao PDR) could be used for the early diagnosis of leptospira
by qPCR.
MATERIALS AND METHODS
Study population. The methodology was optimized using
Leptospira spp. qPCR positive9 and negative samples, collected
as part of studies in different geographical regions of the Lao
PDR (Laos): Vientiane (N = 65), Luang Namtha (N = 51),
and Salavan (N = 18). Samples had tested positive by qPCR
(N = 18), culture (N = 73), or microscopic agglutination tests
(MATs; N = 18) as part of published investigations.5,15
The subsequent prospective study was conducted between
May and August 2014 using consecutive patient samples (N =
363), submitted to the Microbiology Laboratory of Mahosot
Hospital (102.6119°E, 17.9604°N). The inclusion criteria were
fever and/or headache, rash, eschar, myalgia, arthralgia, men-
ingitis, encephalitis, respiratory symptoms, jaundice, and acute
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renal failure. Samples were collected on the day of admission
for molecular diagnostics (serum, EDTA buffy coat, EDTA
whole blood), leptospiral culture (blood clot), serology (serum),
and two aerobic blood culture bottles. The aerobic blood cul-
ture bottles (Pharmaceutical Factory No. 2, Vientiane, Laos),
which contain tryptic hydrolysate of casein and soy peptone
with sodium polyanethol sulfonate (SPS), were inoculated
with blood (> 15 years: 5 mL; 1–15 years: 2 mL; < 1 year:
1 mL), vented, and incubated at 37°C for 7 days.16 Bottles
were manually checked for turbidity and blind subcultures
(blood, chocolate, and MacConkey agars) performed after
24 hours and 7 days of incubation.16
BCF was collected from all blood cultures after 24-hour
incubation. Bottles were repeatedly inverted until blood and
media were homogeneously mixed, and 0.5 mL BCF from
each blood culture bottle was transferred into another tube
(total volume 1–1.5 mL of BCF per patient). Samples were
stored at 4°C for up to 7 days and at −20°C for long term.
All study patients provided written informed consent prior
to sample collection, with parents or guardians of any child
participant providing informed consent on their behalf. Ethical
approval for all investigations was granted by Oxford Tropical
Research Ethics Committee (University of Oxford, United
Kingdom) and the Faculty of Medical Sciences Committee
(University of Health Sciences, Lao PDR).
Sample processing. EDTA blood samples (buffy coat, whole
blood) and serum were processed using the Qiagen Blood
Mini Kit (Qiagen, Germany) as described.15 BCF (0.5 mL)
were spun for 10 minutes at 15,900× g to pellet free bacteria
and cells, but ∼200 μL of the supernatant were discarded
before proceeding as described.14 BCF was processed using
the benzyl alcohol–based method, to remove, combined with
the guanidine hydrochloride lysis/Qiagen Blood Mini Kit
extraction, and obtained a final elution of 50 μL.14
Molecular detection. Leptospira spp. detection was
performed using a published qPCR targeting the rrs gene
(16S rRNA).9 In each run, 5 μL of template DNA (BCF,
buffy coat, whole blood or serum) were added, and when using
BCF-DNA, 40 mg/mL BSAwas included to overcome residual
inhibition due to SPS.17 Each run contained a standard curve
of genomic Leptospira DNA (1 genome equivalent (GE)/μL
to 103 GE/μL; clinical isolate from Laos; assumed genome size,
4.7 Mb). Nontemplate controls were added to each run and
were always negative; that is, no amplification was detected.
All runs were performed using a Rotorgene 6000 (Qiagen).
Analysis. Threshold analysis was performed using
RotorGene™ 6000 software (Version 1.7; Qiagen, Hilden,
Germany). Receiver operator characteristics (ROC) analysis
and figures were prepared using GraphPad Prism (Version
6.0c; San Diego, CA). In accordance with published guidelines,
qPCR results were only considered positive with a Cq-value of
≤ 40 unless otherwise stated.18 MATs were performed by the
WHO/FAO/OIE (World Health Organization/Food and Agri-
culture Organization of the United Nations/World Organiza-
tion for Animal Health) Collaborating Center for Reference
and Research on Leptospirosis, Australia.15 A 4-fold increase
in titer between admission and convalescent samples was con-
sidered as an evidence of acute infection, whereas a 2-fold
increase/decrease and a titer ≥ 1:400 were considered as “evi-
dence of probable or recent infection.” Diagnostic accuracy
was calculated in comparison to culture results, culture +
qPCR, and with culture + qPCR + 4-fold rise in MAT titer.
RESULTS
Pilot study. The retrospective study aimed to pilot the use
of 24-hour incubated BCF samples for molecular diagnosis
and develop appropriate local qPCR threshold values. In total,
BCFs from 109 Leptospira spp. qPCR, culture, or MAT posi-
tive and 63 Leptospira spp. qPCR and MAT negative patients
were used. Each qPCR run was analyzed using three fluores-
cent threshold values (0.05, 0.075, 0.1), to include or exclude
low positive samples and optimize the assay sensitivity and
specificity accordingly (Figure 1). Using ROC analysis, a
threshold level of 0.1 gave the best balance between sensitiv-
ity and specificity with an estimated sensitivity of 65.9% (95%
confidence interval [CI]: 55.3–75.6) and specificity of 95.2%
(95% CI: 86.7–99.0) when compared with culture and qPCR
as a combined gold standard (Table 1). Reducing the thresh-
old and increasing the inclusion Cq would have led to a sensi-
tivity of close to 100% (gold standard: culture) while the
specificity would fall to ∼70% (Figure 1), that is unacceptable
for both clinical diagnostics and public health investigations.
The defined analysis criteria (Cq ≤ 40; fluorescent thresh-
old: 0.1) were subsequently used in a prospective study to
investigate the real-life diagnostic characteristics in a cohort
of Lao hospital patients.
FIGURE 1. Sensitivity and specificity characteristics plotted for
different threshold values. Real-time quantitative polymerase chain
reaction (qPCR) assays were analyzed using three different fluores-
cent thresholds (0.05, 0.075, 0.1), which were set manually. Receiver
operator characteristics (ROC) analysis was used to determine sensi-
tivity and specificity values at different Cq-values. Using (A) culture
and (B) both culture and qPCR (blood) as gold standards for the
ROC analysis.
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Prospective evaluation. Over the study period, 363 consecu-
tive patients meeting the inclusion criteria were recruited. The
majority was male (217/363; 60%), and the median age was
40 years (range: 1–92) with a median of 6 days (0–90 days)
of illness prior to admission. For 352 (97%) patients, BCF and
venous blood sample were available and of those 10 (2.8%)
patients were positive for Leptospira spp. by molecular assays
on admission blood samples (buffy coat, serum, or whole
blood). When BCF after 24-hour incubation was used as a
template for the qPCR, 6/352 (1.7%) patients were positive
by qPCR. Out of these six, only three (50%) patients’ samples
were also positive by qPCR on one or more blood compart-
ments and/or urine (data not shown), whereas seven (70%)
patients with positive blood samples (serum, buffy coat, whole
blood) were negative by qPCR on BCF. The three patients
who were only positive by qPCR on BCF were also positive
for other organisms, either by PCR on EDTA blood (Rickettsia
spp.)20 or blood culture (coagulase-negative Staphylococcus
and Burkholderia cepacia)16 and their sera were negative by
MAT for Leptospira spp. infections. The final sensitivity of
qPCR on BCF when calculated in comparison to venous
blood (buffy coat, serum, whole blood) was 30% with a speci-
ficity of 99%. The positive predictive value (PPV) was only
43%, whereas the negative predictive value was very high
(98%) (Table 1).
In addition to using the predefined criteria (Cq ≤ 40,
threshold: 0.1), including positives with higher Cq-values was
also explored (Table 2). Although the sensitivity doubled to
50% when including all positives with Cq ≤ 45,21 the specific-
ity dropped to 88%. In this prospective study this would have
wrongly identified 41 patients as having leptospirosis, over-
estimating the leptospira frequency in the hospital population
by approximately 4-fold (∼3% versus 13%). Only one of
those 41 false-positive patients (Cq-cutoff: ≤ 45) had serological
evidence for a recent Leptospira spp. infection by MAT.
DISCUSSION
The need for improved molecular tools for Leptospira spp.
diagnosis is reflected in the multitude of new molecular tests
that have been recently developed.21–24 BCF as a sample for
direct detection of leptospirosis has been proposed,14 but no
detailed data on its utility in a clinical laboratory are avail-
able. Our study aimed to establish the optimal methodology
and subsequently to evaluate the method in febrile inpa-
tients. The initial pilot study showed promising sensitivities
of 82%, 90%, 66%, and 59% compared with culture, PCR,
culture + PCR, or culture + PCR + MAT, as the respective
reference standards. These diagnostic characteristics compare
very well with the published sensitivity of the qPCR when
used with whole blood (∼55%),25 suggesting that BCF might
represent a valid and possibly superior blood sample com-
pared with uncultured EDTA blood. However, in the subse-
quent prospective evaluation in a Lao hospital population,
TABLE 1
Diagnostic characteristics obtained by ROC analysis for three different fluorescent cutoffs and different gold standard comparators
Sensitivity (95% CI) Specificity (95% CI) Positive/negative* AUC† (95% CI)
Threshold: 0.05
Culture 89.0% (79.5–95.2) 74.6% (62.1–84.7) 73/63 0.94
qPCR 84.2% (60.4–96.6) 25.4% (15.3–37.9) 19/63 0.57
Culture + qPCR 74.7% (64.5–83.3) 74.6% (62.1–84.7) 91/63 0.82
Culture + qPCR + MAT 66.1% (56.4–74.9) 74.6% (62.1–84.7) 109/63 0.76
Threshold: 0.075
Culture 87.7% (77.9–94.2) 87.3% (76.5–94.3) 73/63 0.95
qPCR 84.2% (60.4–96.6) 25.4% (15.3–37.9) 19/63 0.57
Culture + qPCR 72.5% (62.2–81.4) 87.3% (76.5–94.3) 91/63 0.85
Culture + qPCR + MAT 64.2% (54.5–73.2) 87.3% (76.5–94.3) 109/63 0.79
Threshold: 0.1
Culture 82.2% (71.5–90.2) 95.8% (89.0–99.6) 73/63 0.94
qPCR 89.5% (66.7–98.7) 25.4% (15.3–37.9) 19/63 0.60
Culture + qPCR 65.9% (55.3–75.6) 95.2% (86.7–99.0) 91/63 0.85
Culture + qPCR + MAT 58.7% (48.9–68.1) 95.2% (86.71–99.0) 109/63 0.79
AUC = area under the curve; CI = confidence interval; MAT = microscopic agglutination test; ROC = receiver operator characteristics; qPCR = quantitative real-time polymerase chain reaction.
*Number of positive/negative samples included in the ROC calculation.
†AUC quantifies the overall ability of the test to discriminate between those individuals with the disease and those without the disease (interpretation: 0.9–1 = excellent; 0.8–0.9 = good; 0.7–0.8 = fair;
0.6–0.7 = poor).19
TABLE 2
Sensitivity and specificity of BCF compared with blood when different inclusion criteria are applied for the BCF qPCR
Venous blood qPCR Final diagnostic characteristics for using BCF
Positive Negative Sensitivity (95% CI) Specificity (95% CI) PPV* (%) NPV* (%)
BCF: Cq ≤ 40
BCF Positive 3 4 30% (10.3–60.7) 99% (97–100) 43 98
Negative 7 338
BCF: Cq ≤ 42
Positive 3 18 30% (10.3–60.7) 95% (92–97) 14 98
Negative 7 324
BCF: Cq ≤ 45
Positive 5 41 50% (23.7–76.3) 88% (84–91) 11 98
Negative 5 301
BCF = blood culture fluid; CI = confidence interval; NPV = negative predictive value; PPV = positive predictive value; qPCR = quantitative real-time polymerase chain reaction.
*PPV is the proportion of positive results that are truly positive, and NPV is the proportion of negative results that are truly negative.
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the BCF results underestimated leptospiral incidence in com-
parison to qPCR of uncultured EDTA blood. Seventy percent
of Leptospira spp. positive patients would have been missed
when using only BCF as a sample. Further to highlighting
issues with the use of BCF, our results underline the complex-
ity of leptospira diagnosis with none of the qPCR positive
patients showing evidence for leptospira infection by the sero-
logical gold standard.24,25
The qPCR assay used in this study targets the 16S rRNA
gene of Leptospira spp., and the ubiquity of this target can
result in reduced specificity. A number of studies have
described this issue9,23,26 and our results confirm those findings
as all of the actual false-positive samples had other bacteria
present in the blood or blood culture sample, even though two
of these are likely to have been contaminants. The specificity
and PPV dropped further when the Cq-cutoff was extended to
42 or 45, consistent with the Minimum Information for Publi-
cation of Quantitative Real-Time PCR Experiments (MIQE)
guidelines that suggest that Cq-values > 40 are suspect and
should not be considered positive.18 This trade-off with the
sensitivity has to be accepted, as overestimating disease inci-
dence and initiating the wrong treatment would have adverse
consequences for patients.
Using incubated BCF samples seems advantageous for other
pathogens (O. tsutsugamushi) (S. Dittrich, submitted), but this
does not appear to be the case when using a 16S rRNA-based
qPCR system for leptospirosis. Blood culture bottles containing
glycerol or fatty acids were shown to be conducive to lepto-
spiral growth13; hence, future investigations using supple-
mented blood culture media may be illuminating.
In conclusion, the study shows that, despite the initial
promising results, BCF, when combined with a 16S rRNA-
targeting assay, does not seem sufficiently sensitive and spe-
cific for routine molecular diagnosis of leptospirosis. The
results underline the need for increased investment into
improved diagnostic tools for this important global pathogen.
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